Smith & Nephew (LON:SN) Share Price Passes Above Two Hundred Day Moving Average – Should You Sell?

Smith & Nephew plc (LON:SN) passed above its two hundred day moving average during trading on Thursday . The stock has a two hundred day moving average of GBX 1,049.11 ($13.53) and traded as high as GBX 1,080.50 ($13.94). Smith & Nephew shares last traded at GBX 1,075 ($13.87), with a volume of 1,097,949 shares changing hands.

Wall Street Analysts Forecast Growth

Separately, JPMorgan Chase & Co. reaffirmed an “overweight” rating and issued a GBX 1,180 ($15.22) price objective on shares of Smith & Nephew in a research note on Tuesday, January 14th.

Smith & Nephew Price Performance

The company has a market capitalization of £11.30 billion, a price-to-earnings ratio of 37.10, a price-to-earnings-growth ratio of 0.46 and a beta of 0.62. The company has a 50-day moving average price of GBX 1,075.40 and a 200-day moving average price of GBX 1,048.29. The company has a debt-to-equity ratio of 70.22, a quick ratio of 0.84 and a current ratio of 2.51.

Smith & Nephew Increases Dividend

The company also recently announced a dividend, which will be paid on Wednesday, May 28th. Shareholders of record on Thursday, March 27th will be paid a $0.23 dividend. This represents a yield of 1.61%. The ex-dividend date is Thursday, March 27th. This is an increase from Smith & Nephew’s previous dividend of $0.14. Smith & Nephew’s dividend payout ratio is presently 104.41%.

Insider Transactions at Smith & Nephew

In related news, insider Sybella Stanley acquired 3,810 shares of the business’s stock in a transaction that occurred on Wednesday, March 26th. The shares were acquired at an average cost of GBX 1,101 ($14.20) per share, with a total value of £41,948.10 ($54,112.62). Insiders own 0.19% of the company’s stock.

About Smith & Nephew

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom and internationally. It operates through three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. The company offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures; and other reconstruction products.